Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 15 tags : Approval save search
Johnson & Johnson Vision Announces FDA Approval of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management
Published: 2021-12-15 (Crawled : 23:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
acuvue fda fda approval approval
Home BancShares, Inc. Announces Shareholder Approval in Connection with Happy Bancshares, Inc. Acquisition
Published: 2021-12-15 (Crawled : 23:00) - globenewswire.com
HOMB | News | $23.22 3.52% 0.0% 1.7M
|
Finance
|
| O: 0.86%
H: 0.98%
C: -1.22%
acquisition approval
Eagle Pharmaceuticals Receives FDA Approval for Vasopressin
Published: 2021-12-15 (Crawled : 21:00) - eagleus.com
EGRX | $4.505 2.62% 2.55% 140K
|
Health Technology
|
| O: 0.08%
H: 0.59%
C: -0.69%
fda als fda approval approval
Eli Lilly’s Two-Year Ambition Includes Alzheimer’s Approvals
Published: 2021-12-15 (Crawled : 19:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 4.7%
H: 0.0%
C: 0.0%
alzheimer als approval alzheimer’s alzheimer's
I-Mab Receives IND Approval for Phase 1 Clinical Trial of Bispecific Antibody TJ-CD4B in Solid Tumors in China
Published: 2021-12-15 (Crawled : 15:30) - biospace.com/
IMAB | $1.795 -0.83% -0.84% 140K
|
Health Technology
|
| O: -11.41%
H: 8.08%
C: 7.32%
solid tumors trial approval phase 1 china antibody phase 2
Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve
Published: 2021-12-15 (Crawled : 13:00) - biospace.com/
ARAY | $2.21 0.91% 0.9% 690K
|
Health Technology
|
| O: -2.71%
H: 4.5%
C: 4.28%
cyberknife chronic pain approval
Apellis and Sobi Announce EU Approval of Aspaveli® (pegcetacoplan) for Treatment of PNH
Published: 2021-12-15 (Crawled : 12:30) - globenewswire.com
APLS | $47.51 -1.08% -1.09% 1.9M
|
Health Technology
|
| O: 4.61%
H: 4.76%
C: 3.38%
aspaveli treatment approval
PREIT Makes Meaningful Progress on Key Balance Sheet Improvement Initiatives, Securing Extension of Woodland Mall Mortgage and Unappealable Approval on Multi-Family Development at Moorestown Mall
Published: 2021-12-15 (Crawled : 12:00) - preit.com
PEI 4 | $2.39 0.0%
|
Finance
|
| O: -1.45%
H: 3.92%
C: 1.96%
approval tga
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.